16:17 EDT Maze Therapeutics (MAZE) files to sell 9.23M shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MAZE:
- Maze Therapeutics Appoints Hervé Hoppenot as Chairman
- Maze Therapeutics appoints Herve Hoppenot as chairman of the board
- Two new option listings on September 17th
- Maze Therapeutics price target raised to $34 from $19 at Guggenheim
- Maze Therapeutics price target raised to $50 from $34 at H.C. Wainwright